With operations focused on infection prevention, Bactiguard contributes to the UN’s Sustainable Development Goal: Good health and well-being. Bactiguard’s unique coating technology and product portfolio form an important link in the work to achieve the UN’s goal to eradicate infectious diseases and halt resistance to antibiotics.
Bactiguard’s operations in infection prevention play a key role in the fight to prevent infections and contribute to reducing the use of antibiotics. According to WHO, antibiotic resistance has reached dangerously high levels throughout the world and has developed into a global crisis that has to be tackled urgently. By 2050 ten million people risk dying every year from infections that will not be able to be cured with antibiotics unless the increase in resistance can be halted. People who are infected with antibiotic resistant bacteria are 60 percent more likely to die than those infected by bacteria that are receptive to antibiotics.
Infections that patients acquire during hospital stays or in other healthcare settings (healthcare-associated infections, HAIs) are a growing problem and constitute a threat to global public health. The urinary tract, the respiratory tract and the bloodstream are the most common areas where HAIs occur. These infections often arise as a result of medical or surgical procedures. Medical devices are a common cause of HAIs. According to WHO one in every ten patients suffers from HAIs that lead to antibiotics being prescribed, which speeds up the development of resistance.
Antibiotic resistance is one of the most urgent health risks of our time and threatens to undo a century of medical progress
– Dr. Tedros Adhanom Ghebreyesus, Director General of the WHO.
Significant contribution to the UN’s Sustainable Development Goals
According to WHO, antibiotic resistance is a threat to achieving the UN’s Sustainable Development Goals. The lack of effective treatments for TB, pneumonia and urinary tract infections poses a serious threat to global public health. By preventing infections, Bactiguard contributes directly to the UN’s Sustainable Development Goal 3: Good health and well-being. The UN has stated that good health is essential for people to be able to realize their full potential and contribute to social development.
The aim is to end the epidemics of HIV, tuberculosis, and malaria by 2030 and to combat hepatitis, waterborne and other contagious diseases. This goal is at risk if we do not succeed in our work to prevent HAIs. Bactiguard’s technology and product portfolio help to reduce the risk of infections. Viral infections – for example the coronavirus – places the body’s immune system under stress, which increases the risk of secondary bacterial infections. One of the most serious consequences of bacterial infections is sepsis, which is the leading cause of death around the world and is the cause of one in five deaths. We offer significantly improved infection prevention when using medical devices.
Our daily activities at Bactiguard help in the work to prevent infections. This is how we contribute to achieving the UN’s Global Goals. Infection prevention is therefore not only a strategic issue for Bactiguard, but a central component in healthcare and one of the most important sustainability issues for the future. The most important measure of our success in this work is when the WHO is in a position to report the levels of HAIs falling in the world. The fact that Bactiguard’s infection-inhibiting urinary ract catheters can be used for up to 90 days also contributes to reduced consumption of disposable items while the patient experiences less irritation, reduced risk of infection and a simpler everyday life as the patient does not have to visit the hospital as often in order to change the catheter.